IMBdx (XKRX:461030) Other Current Liabilities : ₩201 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is IMBdx Other Current Liabilities?

IMBdx's other current liabilities for the quarter that ended in Mar. 2024 was ₩201 Mil.

IMBdx's quarterly other current liabilities increased from Sep. 2023 (₩160 Mil) to Dec. 2023 (₩255 Mil) but then declined from Dec. 2023 (₩255 Mil) to Mar. 2024 (₩201 Mil).

IMBdx's annual other current liabilities increased from Dec. 2021 (₩45,528 Mil) to Dec. 2022 (₩47,605 Mil) but then declined from Dec. 2022 (₩47,605 Mil) to Dec. 2023 (₩255 Mil).

IMBdx Other Current Liabilities Historical Data

The historical data trend for IMBdx's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMBdx Other Current Liabilities Chart

IMBdx Annual Data

Trend

Dec21

Dec22

Dec23

Other Current Liabilities

IMBdx Quarterly Data
	Dec22	Mar23	Sep23	Dec23	Mar24
Other Current Liabilities	-	-	-	-	-

IMBdx Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

IMBdx Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of IMBdx's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

IMBdx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IMBdx Inc (XKRX:461030) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

131 Gasandigital 1-ro, 21st Floor BYC Highcity Building A, Geumcheon-gu, Seoul, KOR, 08506

Website

https://www.imbdx.com

IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.

IMBdx Headlines

No Headlines